StockpollyBeta
Get App
Popularity #2,832
CBLL · NASDAQ · Medical - Devices

Ceribell (CBLL)

Lets frontline nurses screen ICU patients for seizures with a six-minute bedside EEG headband.

$23.41
vs last close−0.84 (−3.46%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue121315151719202123252628
Cost of revenue222222233332
Gross profit101113131516181920222326
171921212529323435364446
Research & development233334455567
151718182225282930313839
Selling & marketing101111111315181719192224
General & administrative5677910101111121515
Operating income−7−8−8−8−10−13−14−15−15−15−21−20
000000111111
Interest expense110010000000
Other non-operating income−1−2000−1−2−2−2−2−1−1
Income before tax−7−8−9−9−10−13−13−14−13−14−20−19
Net income from continuing operations−7−8−9−9−10−13−13−14−13−14−20−19
Net income−7−8−9−9−10−13−13−14−13−14−20−19
EPS, basic−$0.30−$0.35−$0.25−$0.26−$0.31−$0.40−$0.36−$0.38−$0.37−$0.36−$0.52−$0.51
EPS, diluted−$0.30−$0.35−$0.25−$0.26−$0.31−$0.40−$0.36−$0.38−$0.37−$0.36−$0.52−$0.51
Weighted average shares, basic232334343431363637373838
Weighted average shares, diluted232334343431363637373838
EBITDA−6−6−8−8−10−12−12−13−13−13−19−19
Depreciation & amortization000000000000
EBIT−7−6−8−8−10−12−12−13−13−13−19−19